Literature DB >> 21903827

Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage.

Esmeralda Valiente1, Lisa F Dawson1, Michelle D Cairns2, Richard A Stabler1, Brendan W Wren1.   

Abstract

Clostridium difficile is the most common cause of antibiotic-associated diarrhoea worldwide. Over the past 10 years, the incidence and severity of disease have increased in North America and Europe due to the emergence of a hypervirulent clone designated PCR ribotype 027. In this study, we sought to identify phenotypic differences among a collection of 26 presumed PCR ribotype 027 strains from the US and the UK isolated between 1988 and 2008 and also re-evaluated the PCR ribotype. We demonstrated that some of the strains typed as BI by restriction endonuclease analysis, and presumed to be PCR ribotype 027, were in fact other PCR ribotypes such as 176, 198 and 244 due to slight variation in banding pattern compared to the 027 strains. The reassigned 176, 198 and 244 ribotype strains were isolated in the US between 2001 and 2004 and appeared to have evolved recently from the 027 lineage. In addition, the UK strains were more motile and more resistant to most of the antibiotics compared to the US counterparts. We conclude that there should be a heightened awareness of newly identified PCR ribotypes such as 176, 198 and 244, and that they may be as problematic as the notorious 027 strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903827      PMCID: PMC4645450          DOI: 10.1099/jmm.0.036194-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  40 in total

1.  Annual incidence of MRSA falls in England, but C difficile continues to rise.

Authors:  Helen Mooney
Journal:  BMJ       Date:  2007-11-10

2.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Authors:  Mohammed Sebaihia; Brendan W Wren; Peter Mullany; Neil F Fairweather; Nigel Minton; Richard Stabler; Nicholas R Thomson; Adam P Roberts; Ana M Cerdeño-Tárraga; Hongmei Wang; Matthew T G Holden; Anne Wright; Carol Churcher; Michael A Quail; Stephen Baker; Nathalie Bason; Karen Brooks; Tracey Chillingworth; Ann Cronin; Paul Davis; Linda Dowd; Audrey Fraser; Theresa Feltwell; Zahra Hance; Simon Holroyd; Kay Jagels; Sharon Moule; Karen Mungall; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Mark Simmonds; Kim Stevens; Louise Unwin; Sally Whithead; Bruno Dupuy; Gordon Dougan; Bart Barrell; Julian Parkhill
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

3.  Multilocus variable-number tandem repeat analysis: a helpful tool for subtyping French Clostridium difficile PCR ribotype 027 isolates.

Authors:  Catherine Eckert; François Vromman; Aurore Halkovich; Frederic Barbut
Journal:  J Med Microbiol       Date:  2011-02-17       Impact factor: 2.472

Review 4.  Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism.

Authors:  J G Bartlett
Journal:  Clin Infect Dis       Date:  1994-05       Impact factor: 9.079

5.  Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.

Authors:  M R Popoff; E J Rubin; D M Gill; P Boquet
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model.

Authors:  A Lee; J L O'Rourke; P J Barrington; T J Trust
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

7.  Flagellin A is essential for the virulence of Vibrio anguillarum.

Authors:  D L Milton; R O'Toole; P Horstedt; H Wolf-Watz
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

8.  Identification and characterization of a fibronectin-binding protein from Clostridium difficile.

Authors:  Claire Hennequin; Claire Janoir; Marie-Claude Barc; Anne Collignon; Tuomo Karjalainen
Journal:  Microbiology       Date:  2003-10       Impact factor: 2.777

9.  Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonization of chickens.

Authors:  Sarah L Howard; Aparna Jagannathan; Evelyn C Soo; Joseph P M Hui; Annie J Aubry; Imran Ahmed; Andrey Karlyshev; John F Kelly; Michael A Jones; Mark P Stevens; Susan M Logan; Brendan W Wren
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more
  30 in total

Review 1.  Dentists, antibiotics and Clostridium difficile-associated disease.

Authors:  N Beacher; M P Sweeney; J Bagg
Journal:  Br Dent J       Date:  2015-09-25       Impact factor: 1.626

2.  Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.

Authors:  Jenessa A Winston; Rajani Thanissery; Stephanie A Montgomery; Casey M Theriot
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

3.  Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains.

Authors:  Vladimir Beran; Dittmar Chmelar; Jana Vobejdova; Adela Konigova; Jakub Nemec; Josef Tvrdik
Journal:  Folia Microbiol (Praha)       Date:  2013-10-11       Impact factor: 2.099

4.  Variation in germination of Clostridium difficile clinical isolates correlates to disease severity.

Authors:  Paul E Carlson; Alyssa M Kaiser; Sarah A McColm; Jessica M Bauer; Vincent B Young; David M Aronoff; Philip C Hanna
Journal:  Anaerobe       Date:  2015-02-11       Impact factor: 3.331

5.  The Clostridium difficile spo0A gene is a persistence and transmission factor.

Authors:  Laura J Deakin; Simon Clare; Robert P Fagan; Lisa F Dawson; Derek J Pickard; Michael R West; Brendan W Wren; Neil F Fairweather; Gordon Dougan; Trevor D Lawley
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

6.  Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012.

Authors:  V Beran; E J Kuijper; C Harmanus; I M Sanders; S M van Dorp; C W Knetsch; J Janeckova; A Seidelova; L Barekova; J Tvrdik; D Chmelar; I Ciznar
Journal:  Folia Microbiol (Praha)       Date:  2017-03-22       Impact factor: 2.099

Review 7.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 8.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 9.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

10.  The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.

Authors:  Robert W McKee; Mihnea R Mangalea; Erin B Purcell; Erin K Borchardt; Rita Tamayo
Journal:  J Bacteriol       Date:  2013-09-13       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.